|1.||Cárdenas, Mariano G: 3 articles (09/2012 - 09/2008)|
|2.||Roguin, Leonor P: 3 articles (09/2012 - 09/2008)|
|3.||Blank, Viviana C: 2 articles (09/2012 - 09/2008)|
|4.||Marder, Mariel: 2 articles (07/2009 - 09/2008)|
|5.||Marder, Mariel N: 1 article (09/2012)|
|6.||Zotta, Elsa: 1 article (07/2009)|
09/01/2012 - "These findings show for the first time the antitumour action of 2'-nitroflavone in haematological cancer cell lines and suggest that both JNK and ERK1/2 cascades are involved in the apoptotic response induced by 2'-nitroflavone in HL-60 cells."
09/01/2012 - "The cytotoxic activity of 2'-nitroflavone was evaluated in different haematological cancer cell lines and its mechanism of action was further studied in HL-60 cells. "
07/01/2009 - "Apoptotic cells were identified by TUNEL assay in tumor slices from mice treated with 10 mg/kg of 2'-nitroflavone. "
07/01/2009 - "Results showed that tumor volume and weight were significantly reduced at doses of 10 and 40 mg/kg of 2'-nitroflavone, respectively. "
07/01/2009 - "The in vivo effect of 2'-nitroflavone on tumor growth was studied in BALB/c mice injected subcutaneously with LM3 cells. "
07/01/2009 - "This is the first report of the in vivo growth inhibitory effect of 2'-nitroflavone as an apoptotic agent likely useful for mammary adenocarcinoma treatment."
07/01/2009 - "We explored the in vitro and in vivo mechanism of antitumor action of the synthetic flavonoid 2'-nitroflavone on LM3 murine mammary adenocarcinoma cells. "
09/08/2008 - "The mechanism of antitumor action of a synthetic nitroflavone derivative, 2'-nitroflavone, was evaluated in vitro in HeLa human cervix adenocarcinoma cells. "